Global prevalence of sexual dysfunction among women with metabolic syndrome: a systematic review and meta-analysis

Nader Salari; Mona Moradi; Amin Hosseinian Far; Yassaman Khodayari; Masoud Mohammadi

doi:10.1007/s40200-023-01267-5

Global prevalence of sexual dysfunction among women with metabolic syndrome: a systematic review and meta-analysis

Nader Salari, Mona Moradi, Amin Hosseinian Far, Yassaman Khodayari, Masoud Mohammadi^*

^*Corresponding author for this work

Business Systems & Operations

Research output: Contribution to Journal › Review Article › peer-review

Abstract

Sexual dysfunction is a common disorder among women, especially during menopause. Metabolic syndrome is a multifactorial disease that, according to previous studies, there is a relationship between the metabolic syndrome and sexual dysfunction among women. The aim of this systematic review and meta-analysis is to obtain the prevalence of Female Sexual Dysfunction (FSD) among women with metabolic syndrome, and to analyze available related evidence. In this systematic review and meta-analysis, the keywords of MeSH, female sexual dysfunction, FSD, metabolic syndrome were searched in PubMed, Web of Science, Scopus, Science Direct and Google Scholar. The searches were conducted without a lower time limit and until May 2022. The prevalence of FSD among women with metabolic syndrome was found to be 39.3% (95% CI: 28.3-51.5). In the subgroup analysis and in the review of 4 studies, the prevalence of sexual dysfunction in postmenopausal women with metabolic syndrome was 49.8% (95% CI: 26.1-73.6). Analyzing the results of the meta-regression test in examining the effect of the three factors of sample size, year of the study, age, and BMI of the patients on the heterogeneity of the meta-analysis, showed that with the increase of the sample size, the prevalence of sexual dysfunction among women with metabolic syndrome decreases (

Original language	English
Pages (from-to)	1011-1019
Number of pages	9
Journal	Journal of Diabetes and Metabolic Disorders
Volume	22
Issue number	2
DOIs	https://doi.org/10.1007/s40200-023-01267-5
Publication status	Published - 28 Jul 2023

Bibliographical note

© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Keywords

BMI
FSD
Female sexual dysfunction
Meta-analysis
Metabolic syndrome

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s40200-023-01267-5

https://link.springer.com/article/10.1007/s40200-023-01267-5#article-info

Cite this

@article{e93ab20ababf4ff7ada5d7e05f888083,

title = "Global prevalence of sexual dysfunction among women with metabolic syndrome: a systematic review and meta-analysis",

abstract = "Sexual dysfunction is a common disorder among women, especially during menopause. Metabolic syndrome is a multifactorial disease that, according to previous studies, there is a relationship between the metabolic syndrome and sexual dysfunction among women. The aim of this systematic review and meta-analysis is to obtain the prevalence of Female Sexual Dysfunction (FSD) among women with metabolic syndrome, and to analyze available related evidence. In this systematic review and meta-analysis, the keywords of MeSH, female sexual dysfunction, FSD, metabolic syndrome were searched in PubMed, Web of Science, Scopus, Science Direct and Google Scholar. The searches were conducted without a lower time limit and until May 2022. The prevalence of FSD among women with metabolic syndrome was found to be 39.3% (95% CI: 28.3-51.5). In the subgroup analysis and in the review of 4 studies, the prevalence of sexual dysfunction in postmenopausal women with metabolic syndrome was 49.8% (95% CI: 26.1-73.6). Analyzing the results of the meta-regression test in examining the effect of the three factors of sample size, year of the study, age, and BMI of the patients on the heterogeneity of the meta-analysis, showed that with the increase of the sample size, the prevalence of sexual dysfunction among women with metabolic syndrome decreases ( ",

keywords = "BMI, FSD, Female sexual dysfunction, Meta-analysis, Metabolic syndrome",

author = "Nader Salari and Mona Moradi and {Hosseinian Far}, Amin and Yassaman Khodayari and Masoud Mohammadi",

note = "{\textcopyright} The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.",

year = "2023",

month = jul,

day = "28",

doi = "10.1007/s40200-023-01267-5",

language = "English",

volume = "22",

pages = "1011--1019",

journal = "Journal of Diabetes and Metabolic Disorders",

issn = "2251-6581",

publisher = "BioMed Central Ltd.",

number = "2",

}

TY - JOUR

T1 - Global prevalence of sexual dysfunction among women with metabolic syndrome: a systematic review and meta-analysis

AU - Salari, Nader

AU - Moradi, Mona

AU - Hosseinian Far, Amin

AU - Khodayari, Yassaman

AU - Mohammadi, Masoud

N1 - © The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

PY - 2023/7/28

Y1 - 2023/7/28

N2 - Sexual dysfunction is a common disorder among women, especially during menopause. Metabolic syndrome is a multifactorial disease that, according to previous studies, there is a relationship between the metabolic syndrome and sexual dysfunction among women. The aim of this systematic review and meta-analysis is to obtain the prevalence of Female Sexual Dysfunction (FSD) among women with metabolic syndrome, and to analyze available related evidence. In this systematic review and meta-analysis, the keywords of MeSH, female sexual dysfunction, FSD, metabolic syndrome were searched in PubMed, Web of Science, Scopus, Science Direct and Google Scholar. The searches were conducted without a lower time limit and until May 2022. The prevalence of FSD among women with metabolic syndrome was found to be 39.3% (95% CI: 28.3-51.5). In the subgroup analysis and in the review of 4 studies, the prevalence of sexual dysfunction in postmenopausal women with metabolic syndrome was 49.8% (95% CI: 26.1-73.6). Analyzing the results of the meta-regression test in examining the effect of the three factors of sample size, year of the study, age, and BMI of the patients on the heterogeneity of the meta-analysis, showed that with the increase of the sample size, the prevalence of sexual dysfunction among women with metabolic syndrome decreases (

AB - Sexual dysfunction is a common disorder among women, especially during menopause. Metabolic syndrome is a multifactorial disease that, according to previous studies, there is a relationship between the metabolic syndrome and sexual dysfunction among women. The aim of this systematic review and meta-analysis is to obtain the prevalence of Female Sexual Dysfunction (FSD) among women with metabolic syndrome, and to analyze available related evidence. In this systematic review and meta-analysis, the keywords of MeSH, female sexual dysfunction, FSD, metabolic syndrome were searched in PubMed, Web of Science, Scopus, Science Direct and Google Scholar. The searches were conducted without a lower time limit and until May 2022. The prevalence of FSD among women with metabolic syndrome was found to be 39.3% (95% CI: 28.3-51.5). In the subgroup analysis and in the review of 4 studies, the prevalence of sexual dysfunction in postmenopausal women with metabolic syndrome was 49.8% (95% CI: 26.1-73.6). Analyzing the results of the meta-regression test in examining the effect of the three factors of sample size, year of the study, age, and BMI of the patients on the heterogeneity of the meta-analysis, showed that with the increase of the sample size, the prevalence of sexual dysfunction among women with metabolic syndrome decreases (

KW - BMI

KW - FSD

KW - Female sexual dysfunction

KW - Meta-analysis

KW - Metabolic syndrome

U2 - 10.1007/s40200-023-01267-5

DO - 10.1007/s40200-023-01267-5

M3 - Review Article

C2 - 37975075

SN - 2251-6581

VL - 22

SP - 1011

EP - 1019

JO - Journal of Diabetes and Metabolic Disorders

JF - Journal of Diabetes and Metabolic Disorders

IS - 2

ER -

Global prevalence of sexual dysfunction among women with metabolic syndrome: a systematic review and meta-analysis

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this